Systematic Assessment of Vascular Risk

This study has been completed.
Information provided by (Responsible Party):
Thomas Lindsay, University Health Network, Toronto Identifier:
First received: September 15, 2006
Last updated: May 12, 2016
Last verified: May 2016

It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.

The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.

Peripheral Vascular Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk

Resource links provided by NLM:

Further study details as provided by University Health Network, Toronto:

Enrollment: 800
Study Start Date: June 2004
Study Completion Date: December 2015
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Those with confirmend PAD

Inclusion Criteria:

All patients who attend the Vascular Surgery Clinic at Toronto General Hospital, St. Michael's Hospital, and St. Joseph's Health Centre who have PAD, cerebrovascular disease (CBVD), or aneurysms will be eligible for this study. Patients who are currently enrolled in other clinical studies are eligible for this study; however proper adherence to the other study will take precedence over of the current proposal.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00378040

Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4
Sponsors and Collaborators
University Health Network, Toronto
Principal Investigator: Thomas Lindsay, M.D Toronto General Hospital, University Health Network
  More Information

Responsible Party: Thomas Lindsay, Professor of Surgery, University Health Network, Toronto Identifier: NCT00378040     History of Changes
Other Study ID Numbers: 01-541S 
Study First Received: September 15, 2006
Last Updated: May 12, 2016
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Peripheral Arterial Disease
Peripheral Vascular Diseases
Vascular Diseases
Arterial Occlusive Diseases
Cardiovascular Diseases processed this record on May 26, 2016